JEM Cancer Immunotherapy 2022
A collection of recent JEM preclinical and clinical studies that develop novel immunotherapies for cancer. Read and learn how we could harness innate immune cells, adaptive immune cells, immunometabolism and engineered cytokines to treat solid and hematologic tumors.
We hope you enjoy reading the collection and encourage your feedback on Twitter at @JExpMed. To learn more about JEM and to submit your research, please visit our Instructions for Authors or contact the editorial office. Sign up to receive future special collections here.
Image © 2022 Schad et al.